IFRX logo

InflaRx N.V. (IFRX)

Profile

Full Name

InflaRx N.V.

Ticker

NASDAQ: IFRX

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Germany

IPO

November 7, 2017

Indexes

Not included

Website

https://www.inflarx.de

Employees

74

Key Details

Price

$0.99(-14.30%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$179.30K(162.90% YoY)

Annual EPS

-$0.85(-0.73% YoY)

PE Ratio

-

Next earnings date

Mar 19, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $0.99
    IFRX price is $0.99

    30-Day Relative Volume

    0.25
    IFRX 30-day relative volume is 0.25

    Price Performance

    Price 1-Day Change

    -14.3%
    IFRX price is down -14.3% today

    Price YTD Change

    -59.75%
    IFRX price is down -59.75% since January 1st

    Price 1-Year Change

    -58.41%
    IFRX price is down -58.41% year-on-year

    Price 3-Year Change

    -61.62%
    IFRX price is down -61.62% over the past 3 years

    Price Range

    Price All-Time High

    $53.10
    IFRX price is currently -98.13% below its historical high of $53.10

    Price 3-Year Low

    $0.71
    IFRX price is currently +39.82% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $67.35M
    IFRX market cap is $67.35 million

    Market Cap 3-Year Change

    -41.18%
    IFRX market cap is down -41.18% over the past 3 years

    Market Cap All-Time High

    $1.34B
    IFRX market cap is currently -94.97% below its historical high of $1.34 billion

    Market Cap Sector Percentile

    36.97%
    IFRX market cap is higher than 36.97% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +15.05%
    IFRX shares outstanding is up +15.05% year-on-year

    Shares Outstanding 3-Year Change

    +53.26%
    IFRX shares outstanding is up +53.26% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    1.31
    IFRX beta is 1.31

    200-day SMA

    $1.20
    IFRX price is currently -17.23% below its 200-day simple moving average

    50-day SMA

    $1.33
    IFRX price is currently -25.10% below its 50-day simple moving average

    14-Day RSI

    39.66
    IFRX 14-day relative strength index is 39.66

    Volume

    0.25
    IFRX 30-day relative volume is 0.25

    ATR

    $0.15
    IFRX average true range is $0.15

    10-day Historical Volatility

    86.53%
    IFRX 10-day historical volatility is 86.53%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $179.30K
    IFRX annual revenue is $179.30 thousand

    Revenue Analysts Estimate

    $67.88K
    IFRX annual revenue is currently +164.14% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    +162.9%
    IFRX annual revenue is up +162.9% year-on-year

    Revenue Sector Percentile

    32.39%
    IFRX annual revenue is higher than 32.39% of companies in Healthcare sector

    EPS

    EPS

    -$0.85
    IFRX annual earnings per share is -$0.85

    EPS Analysts Estimate

    -$0.67
    IFRX annual earnings per share is currently -25.75% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -0.73%
    IFRX annual earnings per share is down -0.73% year-on-year

    EPS Sector Percentile

    59.73%
    IFRX annual earnings per share is higher than 59.73% of companies in Healthcare sector

    Profit

    Gross Profit

    -$3.41M
    IFRX annual gross profit is -$3.41 million

    Gross Margin

    -2175.91%
    IFRX annual gross profit margin is -2175.91%

    Operating Profit

    -$57.37M
    IFRX annual operating income is -$57.37 million

    Operating Margin

    -35.17K%
    IFRX annual operating profit margin is -35.17 thousand%

    Net Income

    -$49.83M
    IFRX annual net profit is -$49.83 million

    Net Margin

    -27.79K%
    IFRX annual net profit margin is -27.79 thousand%

    Expenses

    Total Expenses

    $57.55M
    IFRX annual total expenses is $57.55 million

    Operating Expenses

    $53.96M
    IFRX annual total operating expenses is $53.96 million

    Cost Of Goods Sold

    $4.08M
    IFRX annual cost of goods sold is $4.08 million

    Selling, General & Administrative Expenses

    $20.92M
    IFRX annual SG&A is $20.92 million

    Depreciation & Amortization

    $525.10K
    IFRX annual D&A is $525.10 thousand

    Interest Expense

    $0.00
    IFRX annual interest expense is $0.00

    Income Tax

    $5600.00
    IFRX annual income tax is $5600.00

    EBIT & EBITDA

    EBIT

    -$49.83M
    IFRX annual earnings before interest & taxes is -$49.83 million

    EBITDA

    -$49.30M
    IFRX annual EBITDA is -$49.30 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $78.72M
    IFRX annual total assets is $78.72 million

    Non Current Assets

    $4.54M
    IFRX annual long term assets is $4.54 million

    Current Assets

    $74.56M
    IFRX annual total current assets is $74.56 million

    Cash and Cash Equivalents

    $19.12M
    IFRX annual cash & cash equivalents is $19.12 million

    Accounts Receivable

    -
    IFRX annual accounts receivable value is unknown

    Inventory

    $7.14M
    IFRX annual inventory is $7.14 million

    Liabilities

    Total Liabilities

    $15.12M
    IFRX annual total liabilities is $15.12 million

    Long Term Liabilities

    $453.60K
    IFRX annual total long term liabilities is $453.60 thousand

    Current Liabilities

    $14.74M
    IFRX annual current liabilities is $14.74 million

    Accounts Payable

    $11.86M
    IFRX annual accounts payable is $11.86 million

    Debt

    Total Debt

    $833.70K
    IFRX annual total debt is $833.70 thousand

    Total Debt 1-Year Change

    -32.62%
    IFRX annual total debt is down -32.62% year-on-year

    Long Term Debt

    $413.20K
    IFRX annual long term debt is $413.20 thousand

    Short Term Debt

    $420.40K
    IFRX annual short term debt is $420.40 thousand

    Equity & Capital

    Shareholders Equity

    $63.60M
    IFRX annual stockholders equity is $63.60 million

    Book Value

    $63.91M
    IFRX annual book value is $63.91 million

    Retained Earnings

    -$345.67M
    IFRX annual retained earnings is -$345.67 million

    Working Capital

    $59.53M
    IFRX annual working capital is $59.53 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$52.56M
    IFRX annual cash from operations is -$52.56 million

    Cash From Operations 1-Year Change

    -28.38%
    IFRX annual cash from operations is down -28.38% year-on-year

    Cash From Investing

    $56.68M
    IFRX annual cash from investing is $56.68 million

    Cash From Investing 1-Year Change

    +395.83%
    IFRX annual cash from investing is up +395.83% year-on-year

    Cash From Financing

    $418.30K
    IFRX annual cash from financing is $418.30 thousand

    Cash From Financing 1-Year Change

    -99.27%
    IFRX annual cash from financing is down -99.27% year-on-year

    CAPEX

    CAPEX

    $50.70K
    IFRX annual capital expenditures is $50.70 thousand

    CAPEX 1-Year Change

    -42.19%
    IFRX annual capital expenditures is down -42.19% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$52.61M
    IFRX annual free cash flow is -$52.61 million

    Free Cash Flow 1-Year Change

    -28.23%
    IFRX annual free cash flow is down -28.23% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    -2175.91%
    IFRX annual gross profit margin is -2175.91%

    Operating Margin

    -35.17K%
    IFRX annual operating profit margin is -35.17 thousand%

    Net Margin

    -27.79K%
    IFRX annual net profit margin is -27.79 thousand%

    ROA & ROE

    ROA

    -47.12%
    IFRX annual return on assets is -47.12%

    ROE

    -56.33%
    IFRX annual return on equity is -56.33%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    IFRX price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    IFRX price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.26
    IFRX price to book ratio is 1.26

    PB Ratio Sector Percentile

    40.68%
    IFRX price to book ratio is higher than 40.68% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    928.93
    IFRX price to sales ratio is 928.93

    PS Ratio Sector Percentile

    97.1%
    IFRX price to sales ratio is higher than 97.1% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $16.03M
    IFRX enterprise value is $16.03 million

    Enterprise Value Sector Percentile

    25.59%
    IFRX enterprise value is higher than 25.59% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -0.39
    IFRX EV/EBITDA is -0.39

    EV/EBITDA Sector Percentile

    54.51%
    IFRX EV/EBITDA is higher than 54.51% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    5.06
    IFRX annual current ratio is 5.06

    Quick Ratio

    4.57
    IFRX annual quick ratio is 4.57

    Leverage

    Debt To Equity

    0.01
    IFRX annual debt to equity ratio is 0.01

    Interest Coverage Ratio

    -
    IFRX annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    2
    IFRX piotroski f-score is 2

    Altman Z-Score

    -4.65
    IFRX altman z-score is -4.65

    Analyst ratings

    Recent major analysts updates

    Nov 10, 25 Guggenheim
    Buy
    May 29, 25 Oppenheimer
    Outperform
    May 8, 25 Oppenheimer
    Outperform
    Apr 29, 25 Cantor Fitzgerald
    Overweight
    Mar 26, 25 Guggenheim
    Buy
    Mar 21, 25 HC Wainwright & Co.
    Buy
    Mar 7, 25 HC Wainwright & Co.
    Buy
    Jan 16, 25 HC Wainwright & Co.
    Buy
    Dec 20, 24 HC Wainwright & Co.
    Buy
    Nov 15, 24 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with IFRX included

    Growing Shares Outstanding
    Stocks cheaper than 1 dollar
    Stocks with high beta
    Stocks below SMA 200
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Biotech Companies
    • What is the ticker symbol for InflaRx N.V.?
    • Does InflaRx N.V. pay dividends?
    • What sector is InflaRx N.V. in?
    • What industry is InflaRx N.V. in?
    • What country is InflaRx N.V. based in?
    • When did InflaRx N.V. go public?
    • Is InflaRx N.V. in the S&P 500?
    • Is InflaRx N.V. in the NASDAQ 100?
    • Is InflaRx N.V. in the Dow Jones?
    • When was InflaRx N.V.'s last earnings report?
    • When does InflaRx N.V. report earnings?

    What is the ticker symbol for InflaRx N.V.?

    The ticker symbol for InflaRx N.V. is NASDAQ:IFRX

    Does InflaRx N.V. pay dividends?

    No, InflaRx N.V. does not pay dividends

    What sector is InflaRx N.V. in?

    InflaRx N.V. is in the Healthcare sector

    What industry is InflaRx N.V. in?

    InflaRx N.V. is in the Biotechnology industry

    What country is InflaRx N.V. based in?

    InflaRx N.V. is headquartered in Germany

    When did InflaRx N.V. go public?

    InflaRx N.V.'s initial public offering (IPO) was on November 7, 2017

    Is InflaRx N.V. in the S&P 500?

    No, InflaRx N.V. is not included in the S&P 500 index

    Is InflaRx N.V. in the NASDAQ 100?

    No, InflaRx N.V. is not included in the NASDAQ 100 index

    Is InflaRx N.V. in the Dow Jones?

    No, InflaRx N.V. is not included in the Dow Jones index

    When was InflaRx N.V.'s last earnings report?

    InflaRx N.V.'s most recent earnings report was on November 10, 2025

    When does InflaRx N.V. report earnings?

    The next expected earnings date for InflaRx N.V. is March 19, 2026
    On this page